
Israeli drug development firm VBL Therapeutics has been left reeling after it announced that its lead oncology product ofranergene obadenovec, …

A team of researchers at the Minneapolis Veterans Affairs Health Care System has found that, for all their risks, opioids …

Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …

Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …

Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine …

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …

Theratechnologies has revealed that Trogarzo has received approval from the FDA as a treatment of HIV-1 in patients with multidrug-resistant …

A former Sanofi executive fired for sexting, indecent exposure and other alleged sexual harassment charges has been demanding up to …

In what they believe is the first study of its kind, a team of researchers at the University of Massachusetts …

Through a concerted shift from branded drugs to generic equivalents as a means to lower prescription costs, Japan is estimated …

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have …

Gilead has unveiled findings from two Phase 3 studies into the efficacy of switching to its three-drug combo Biktarvy (bictegravir/emtricitabine/tenofovir …

A team of researchers from Australia’s University of Adelaide have developed a new method to fighting antibiotic-resistant bacteria by starving …

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …